Development of a Probiotic Strategy to Prevent or Eliminate Nasal Colonization With S. Aureus
NCT00977496 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2015-03-18
Summary
The goal of this study is characterize the changes in bacterial diversity of the nares of hemodialysis patients. Another goal is to determine when hemodialysis patients become colonized with the bacteria Staphylococcus aureus, as nasal colonization with S. aureus is a major risk factor for invasive infection in hemodialysis patients. Fifteen subjects will be recruited into the study. Nasal swabs will be collected every month for six months or until one month after S. aureus colonization in order to determine any changes in the bacterial communities of the nose. Clinical data will also be collected to evaluate the possible influence of external factors on changes in the microbial communities in the patients' noses. This study will provide preliminary data on whether oral- and/or nasal-administered probiotics can eliminate nasal carriage of S. aureus.
Conditions
- Hemodialysis
Interventions
- PROCEDURE
-
Nasal Swab
Swabs will be moistened in sterile 0.9% sodium chloride solution and rotated in the anterior vestibule of both nares and processed for S aureus cultures and for bacterial DNA extraction.
Sponsors & Collaborators
-
Tufts Medical Center
lead OTHER
Principal Investigators
-
Patricia L Hibberd, MD, PhD · Tufts Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-05-31
More Related Trials
-
Using Antibiotics to Prevent Infections in Hemodialysis Patients During Catheter Placement
NCT06814223 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy of a Short-term Sequential Therapy in Non-complicated Catheter Related Bacteremia by Methicillin- Susceptible S.Aureus.
NCT01875263 ·Status: TERMINATED ·Phase: PHASE3
-
Coagulation and Fibrinolysis as Virulence Factors for Invasive Staphylococcus Aureus and Streptococcus Infections
NCT01731483 ·Status: COMPLETED
-
Staphylococcus Aureus Bacteremia Antibiotic Treatment Options
NCT01792804 ·Status: COMPLETED ·Phase: PHASE3
-
S. Aureus Decolonization in HPN Patients.
NCT03173053 ·Status: TERMINATED ·Phase: NA
-
Seven Versus Fourteen Days of Treatment in Uncomplicated Staphylococcus Aureus Bacteremia
NCT03514446 ·Status: UNKNOWN ·Phase: PHASE4
-
Mupirocin 2% Ointment Vs Spray Antibiotics on Temporary Hemodialysis Catheter
NCT05874219 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Oral Sodium Fusidate (CEM-102) for the Treatment of Staphylococcal Bone or Joint Infections
NCT02569541 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Povidone-Iodine for Nasal Decolonization
NCT05529173 ·Status: COMPLETED ·Phase: PHASE4
-
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
NCT02570490 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection
NCT01191840 ·Status: COMPLETED ·Phase: PHASE2
-
Direct Thrombin Inhibitors Versus LMWH in Staphylococcus Aureus Bacteraemia
NCT01911624 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Nephrotoxicity and Hospital Costs in Patients With Methicillin-Resistant Staphylococcus Aureus Bacteremia Who Received Vancomycin Versus Teicoplanin Therapy
NCT01352936 ·Status: UNKNOWN
-
Risk Factors for Linezolid Resistance in Staphylococcus Aureus
NCT00519025 ·Status: COMPLETED
-
Target Attainment of Continuous Infusion Flucloxacillin and Cefazolin Coupled With TDM vs. Standard of Care Treatment in Patients With Complicated S. Aureus Infection
NCT05655091 ·Status: RECRUITING ·Phase: PHASE2
-
Red Light Photobiomodulation and Topical Disinfectants
NCT05797818 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Virulence of Staphylococcus Lugdunensis in Severe Infections
NCT02026895 ·Status: COMPLETED ·Phase: NA
-
Nasal Tea Tree Oil for the Prevention of Infections in PD Patients
NCT01214395 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Pre-surgical Nasal Bacterial Reduction on Postoperative Surgical Site Infections / Standard Care Change
NCT01148030 ·Status: TERMINATED
-
Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia
NCT04886284 ·Status: RECRUITING ·Phase: PHASE2
-
The Effectiveness of Antimicrobial Breathing System on the Presence of Multidrug-resistant Organisms
NCT04927806 ·Status: COMPLETED ·Phase: NA
-
Pulsed UV Xenon Disinfection to Prevent Resistant Healthcare Associated Infection
NCT03349268 ·Status: COMPLETED ·Phase: NA
-
Rifampin-free Regimen Versus Rifampin-containing Regimen in the Treatment of Staphylococcal Prosthetic Valve Endocarditis
NCT07345325 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Subphenotype- and Complication-guided Adjunctive Fosfomycin Therapy for Staphylococcus Aureus Bacteraemia
NCT07155590 ·Status: ACTIVE_NOT_RECRUITING
-
Bacteriophage Therapy in First Time Chronic Prosthetic Joint Infections
NCT05269121 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2